| A stress-induced early innate response causes multidrug tolerance in melanoma D Ravindran Menon, S Das, C Krepler, A Vultur, B Rinner, S Schauer, ... Oncogene 34 (34), 4448-4459, 2015 | 178* | 2015 |
| Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion IW Tengesdal, DR Menon, DG Osborne, CP Neff, NE Powers, F Gamboni, ... Proceedings of the National Academy of Sciences 118 (10), e2000915118, 2021 | 109 | 2021 |
| CDK1 interacts with Sox2 and promotes tumor initiation in human melanoma D Ravindran Menon, Y Luo, JJ Arcaroli, S Liu, LN KrishnanKutty, ... Cancer research 78 (23), 6561-6574, 2018 | 107 | 2018 |
| hSSB1 interacts directly with the MRN complex stimulating its recruitment to DNA double-strand breaks and its endo-nuclease activity DJ Richard, L Cubeddu, AJ Urquhart, A Bain, E Bolderson, D Menon, ... Nucleic acids research 39 (9), 3643-3651, 2011 | 96 | 2011 |
| Distinct histone modifications denote early stress-induced drug tolerance in cancer A Al Emran, DM Marzese, DR Menon, MS Stark, J Torrano, ... Oncotarget 9 (9), 8206, 2018 | 60 | 2018 |
| Notch4 signaling induces a Mesenchymal–Epithelial–like transition in melanoma cells to suppress malignant behaviors E Bonyadi Rad, H Hammerlindl, C Wels, U Popper, D Ravindran Menon, ... Cancer research 76 (7), 1690-1697, 2016 | 54 | 2016 |
| Egcg inhibits tumor growth in melanoma by targeting jak-stat signaling and its downstream Pd-L1/Pd-L2-Pd1 axis in tumors and enhancing cytotoxic T-cell responses D Ravindran Menon, Y Li, T Yamauchi, DG Osborne, PK Vaddi, ... Pharmaceuticals 14 (11), 1081, 2021 | 43 | 2021 |
| Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer DR Menon, H Hammerlindl, J Torrano, H Schaider, M Fujita Theranostics 10 (14), 6261, 2020 | 39 | 2020 |
| Inflammasome sensor NLRP1 confers acquired drug resistance to temozolomide in human melanoma Z Zhai, JM Samson, T Yamauchi, PK Vaddi, Y Matsumoto, CA Dinarello, ... Cancers 12 (9), 2518, 2020 | 24 | 2020 |
| Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes JM Samson, DR Menon, DE Smith, E Baird, T Kitano, D Gao, AC Tan, ... Chemico-biological interactions 314, 108822, 2019 | 23 | 2019 |
| Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS-Mutant Cancers H Hammerlindl, D Ravindran Menon, S Hammerlindl, AA Emran, ... Clinical Cancer Research 24 (5), 1090-1102, 2018 | 18 | 2018 |
| Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer AA Emran, DM Marzese, DR Menon, H Hammerlindl, F Ahmed, E Richtig, ... Epigenomics 11 (7), 732-737, 2019 | 14 | 2019 |
| TGF‐β1 and TNF‐α differentially regulate Twist1 mediated resistance towards BRAF/MEK inhibition in melanoma DR Menon, C Wels, E Bonyadi Rad, S Joshi, H Knausz, J Lade‐Keller, ... Pigment cell & melanoma research 26 (6), 912-916, 2013 | 14 | 2013 |
| Computational modeling of NLRP3 identifies enhanced ATP binding and multimerization in cryopyrin-associated periodic syndromes JM Samson, D Ravindran Menon, PK Vaddi, N Kalani Williams, ... Frontiers in Immunology 11, 584364, 2020 | 10 | 2020 |
| Microenvironment-driven resistance to BRAF inhibition comes of age DR Menon, H Schaider Journal of Investigative Dermatology 135 (12), 2923-2925, 2015 | 8 | 2015 |
| Dual targeting autoinflammation and PD-L1/L2 immune checkpoint by EGCG augments anti-tumor effects in melanoma Y Li, DR Menon, D Mathew, R Torres, M Fujita Journal of Investigative Dermatology 139 (5), S145, 2019 | 7 | 2019 |
| A state of stochastic cancer stemness through the CDK1-SOX2 axis RM Dinoop, F Mayumi oncotarget 10 (27), 2583-2585, 2019 | 6 | 2019 |
| CTLA4 mRNA is downregulated by miR-155 in regulatory T cells, and reduced blood CTLA4 levels are associated with poor prognosis in metastatic melanoma … PK Vaddi, DG Osborne, A Nicklawsky, NK Williams, DR Menon, D Smith, ... Frontiers in Immunology 14, 1173035, 2023 | 4 | 2023 |
| Global melanoma correlations with obesity, smoking, and alcohol consumption N Batta, S Shangraw, A Nicklawsky, T Yamauchi, Z Zhai, ... JMIR dermatology 4 (2), e31275, 2021 | 3 | 2021 |
| H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase DR Menon, H Hammerlindl, G Gimenez, S Hammerlindl, E Zuegner, ... Drug Resistance Updates 71, 100993, 2023 | 2 | 2023 |
Helmut SchaiderThe University of QueenslandVerified email at uq.edu.au
